Background: Neonatal acute kidney injury (NAKI) is relatively common, with increasing incidence globally. Infants with NAKI are at increased risk of long-term chronic kidney disease, or death. Although serum creatinine is still presently used as an index of renal function, it is an insensitive and poor marker of renal injury. The use of serum creatinine leads to delay in the detection and intervention in the early periods of renal injury when appropriate management strategies can be instituted before irreversible renal damage occurs. Urine NGAL is presently the most expressed protein in the kidney following ischemia and has been found to be a very sensitive and specific early marker of AKI before renal failure sets in. Early dia...
BackgroundAcute kidney injury (AKI) is common in preterm infants and is associated with high mortali...
Renal precision medicine in neonates is useful to support decision making on pharmacotherapy, signal...
Introduction: Acute kidney injury biomarkers are opening a new era in diagnosing kidney failure. T...
Introduction: Perinatal asphyxia is a major cause of neonatal morbidity and mortality. Acute kidney ...
Introduction: Perinatal asphyxia is a major cause of neonatal morbidity and mortality. Acute kidney ...
Introduction: Perinatal asphyxia is a major cause of neonatal morbidity and mortality. Acute kidney ...
Background: Acute kidney injury (AKI) is the most common complication of perinatal asphyxia. Recent ...
Background Infants with neonatal asphyxia have multiorgan damage, such as to the kidneys (50%), cent...
Background: Acute kidney injury (AKI) is the most common complication of perinatal asphyxia. Recent ...
Background: Acute kidney injury (AKI) is the most common complication of perinatal asphyxia. Recent ...
Background: Acute kidney injury (AKI) is the most common complication of perinatal asphyxia. Recent ...
Introduction: Acute kidney injury (AKI) is common in neonatal intensive care units (NICU). In recent...
Background/aim: Congenital heart disease (CHD) is the most common congenital malformation group and ...
Neutrophil gelatinase-associated lipocalin (NGAL) is postulated to be a potentially new and highly ...
Background: Acute kidney injury (AKI) is common in preterm infants and is associated with high morta...
BackgroundAcute kidney injury (AKI) is common in preterm infants and is associated with high mortali...
Renal precision medicine in neonates is useful to support decision making on pharmacotherapy, signal...
Introduction: Acute kidney injury biomarkers are opening a new era in diagnosing kidney failure. T...
Introduction: Perinatal asphyxia is a major cause of neonatal morbidity and mortality. Acute kidney ...
Introduction: Perinatal asphyxia is a major cause of neonatal morbidity and mortality. Acute kidney ...
Introduction: Perinatal asphyxia is a major cause of neonatal morbidity and mortality. Acute kidney ...
Background: Acute kidney injury (AKI) is the most common complication of perinatal asphyxia. Recent ...
Background Infants with neonatal asphyxia have multiorgan damage, such as to the kidneys (50%), cent...
Background: Acute kidney injury (AKI) is the most common complication of perinatal asphyxia. Recent ...
Background: Acute kidney injury (AKI) is the most common complication of perinatal asphyxia. Recent ...
Background: Acute kidney injury (AKI) is the most common complication of perinatal asphyxia. Recent ...
Introduction: Acute kidney injury (AKI) is common in neonatal intensive care units (NICU). In recent...
Background/aim: Congenital heart disease (CHD) is the most common congenital malformation group and ...
Neutrophil gelatinase-associated lipocalin (NGAL) is postulated to be a potentially new and highly ...
Background: Acute kidney injury (AKI) is common in preterm infants and is associated with high morta...
BackgroundAcute kidney injury (AKI) is common in preterm infants and is associated with high mortali...
Renal precision medicine in neonates is useful to support decision making on pharmacotherapy, signal...
Introduction: Acute kidney injury biomarkers are opening a new era in diagnosing kidney failure. T...